Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schimmel & Co. was a preeminent German chemical company founded in 1829, world-renowned for its pioneering work in the research and production of essential oils, fragrances, and flavorings. Based in Miltitz, near Leipzig, the company was a global leader in terpene chemistry and published the influential "Schimmel Reports," which served as the definitive scientific resource for the industry for over a century. While primarily focused on aromatics, its research laid the groundwork for modern pharmacognosy and the isolation of bioactive compounds from plants. The company's innovations in distillation and synthetic chemistry significantly advanced the quality standards for ingredients used in both the pharmaceutical and consumer goods industries. Following the reunification of Germany, the company's legacy and Miltitz manufacturing facilities were acquired by Bell Flavors & Fragrances in 1993.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schimmel & Co..